A unique nanocluster of copper atoms created by Kaust researchers could serve as a roadmap to guide the design of new catalysts and imaging agents.

With the takeover of Andrew Alliance, Waters Corporation intends to strengthen its core business of analytical system solutions and also expand its technology portfolio for the benefit of its customers across the pharmaceutical, life sciences and materials science industries.

Quick and straightforward, aqueous size exclusion chromatography (SEC) has become a mainstay for the analysis of protein aggregates in the biopharmaceutical industry. Coupling SEC with advanced detection, such as mass spectrometry, light scattering or surface plasmon resonance, makes it a versatile tool for numerous applications beyond aggregate analysis.

Thermo Fisher Scientific and Symphogen, a clinical-stage antibody oncology-focused company, have entered into a two-year collaborative partnership to deliver validated, platform workflows for simplified characterization and quality monitoring of complex therapeutic proteins.

Pharmaceutical scientists are now able to overcome challenges associated with the identification and characterization of small molecules and their fragments with Thermo Scientific Mass Frontier 8.0 software, which quickly translates complex data into actionable, sharable knowledge.

Waters Corporation has introduced the Bio Accord System. This purposefully designed liquid chromatography-mass spectrometry (LC-MS) solution is to expand access to high-resolution time-of-flight mass spectrometry capabilities to more scientists.

Since Waters acquired TA Instruments in 1996, the company has been an integral part of the group. This year TA Instruments is presenting several new products at Pittcon. Waters will also be presenting an LC-MS system specifically for biopharmaceutical analysis.

Researchers led by the Technical University of Munich (TUM) report on the synthesis of a library of more than 330,000 reference peptides representing essentially all canonical proteins of the human proteome. This research is a major milestone in the ProteomeTools project which aims at translating human proteome information into new molecular and digital tools with the potential for use in drug discovery, personalized medicine and life science research.

A study, conducted by a research group of the UPV/EHU-University of the Basque Country, has analysed the diet of Muslim individuals at the Tauste (Zaragoza) site and has determined the differences existing in diet according to sex and age.

Thermo Fisher offers a new technology for single quadrupole mass spectrometer. The system is designed for ease-of-use while offering application flexibility and reliable results for challenging mass confirmation analyses, the company says.